Zobrazeno 1 - 10
of 1 169
pro vyhledávání: '"Kluetz PG"'
Autor:
Fallah J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Heiss BL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Joeng HK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Weinstock C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gao X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pierce WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Chukwurah B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bhatnagar V; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Fiero MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Suzman DL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Nov 15; Vol. 30 (22), pp. 5003-5008.
Autor:
Fallah J; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Mulkey F; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Fiero MH; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Gittleman H; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Song C; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Puthiamadathil J; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Amatya A; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Agrawal S; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Vellanki P; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Suzman DL; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Singh H; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence (OCE), US Food and Drug Administration, Silver Spring, MD., Amiri-Kordestani L; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence (OCE), US Food and Drug Administration, Silver Spring, MD., Mishra-Kalyani P; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Pazdur R; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence (OCE), US Food and Drug Administration, Silver Spring, MD., Kluetz PG; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence (OCE), US Food and Drug Administration, Silver Spring, MD.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov 10; Vol. 42 (32), pp. 3783-3787. Date of Electronic Publication: 2024 Sep 17.
Autor:
Rivera DR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Eckert JC; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Rodriguez-Watson C; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Lerro CC; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Bertagnolli MM; Alliance for Clinical Trials in Oncology, Brigham & Women's Hospital, Boston, Massachusetts, USA., Hubbard RA; Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Lund JL; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Schrag D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Wang SV; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wood WA; Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lee JJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Okafor C; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Ghauri K; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Winckler SC; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Kluetz PG; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Nov; Vol. 33 (11), pp. e5818.
Autor:
Brave MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Maguire WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Weinstock C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Zhang H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gao X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Li F; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Yu J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Fu W; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Zhao H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pierce WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chang E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Dinin J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Fiero MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Rahman NA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Suzman DL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Nov 01; Vol. 30 (21), pp. 4815-4821.
Autor:
Agrawal S; United States Food and Drug Administration, Silver Spring, MD, United States., Lee C; United States Food and Drug Administration, Silver Spring, Maryland, United States., Pierce WF; Food and Drug Administration, Silver Spring, Maryland, United States., Everhart E; United States Food and Drug Administration, Silver Spring, MD, United States., King-Ducre A; Food and Drug Administration, Silver Spring, Maryland, United States., Royce M; United States Food and Drug Administration, Silver Spring, Maryland, United States., Osgood CL; United States Food and Drug Administration, Silver Spring, MD, United States., Amiri-Kordestani L; Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, United States., Chiu HJ; Food and Drug Administration, Silver Spring, Maryland, United States., Ricks TK; United States Food and Drug Administration, Silver Spring, MD, United States., Pan L; United States Food and Drug Administration, Silver Spring, Maryland, United States., Fourie Zirkelbach J; United States Food and Drug Administration, Silver Spring, Maryland, United States., Charlab R; United States Food and Drug Administration, Silver Spring, MD, United States., Pacanowski M; United States Food and Drug Administration, Silver Spring, MD, United States., Kim T; United States Food and Drug Administration, Silver Spring, MD, United States., Pazdur R; United States Food and Drug Administration, Silver Spring, MD, United States., Kluetz PG; Food and Drug Administration, Silver Spring, MD, United States., Gao JJ; United States Food and Drug Administration, Silver Spring, MD, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.
Autor:
Fallah J; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Gittleman H; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Weinstock C; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Chang E; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Agrawal S; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Tang S; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Pazdur R; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Kluetz PG; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Suzman DL; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Amiri-Kordestani L; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Sep 01; Vol. 116 (9), pp. 1534.
Autor:
Duke ES; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Bradford D; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Sinha AK; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Mishra-Kalyani PS; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Lerro CC; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD., Rivera D; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD., Wearne E; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Miller CP; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Leighton J; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Sabit H; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Zhao H; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Lane A; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Scepura B; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Pazdur R; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD., Singh H; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD., Kluetz PG; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD., Donoghue M; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD., Drezner N; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 01; Vol. 42 (25), pp. 3047-3057. Date of Electronic Publication: 2024 Jun 25.
Autor:
George S; Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, USA., Campbell N; Data Innovation Lab LLC, Alliance for Clinical Trials in Oncology, Boston, Massachusetts, USA., Hillman SL; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota, USA., Harlos ES; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota, USA., Stein DWJ; The MITRE Corporation, Bedford, Massachusetts, USA., Chan MY; The MITRE Corporation, Bedford, Massachusetts, USA., Chow SL; Alliance for Clinical Trials in Oncology, Chicago, Illinois, USA., Elrahi CL; Data Innovation Lab LLC, Alliance for Clinical Trials in Oncology, Boston, Massachusetts, USA., Quina AC; The MITRE Corporation, Bedford, Massachusetts, USA., Kokolus MC; The MITRE Corporation, Bedford, Massachusetts, USA., Casagni MD; The MITRE Corporation, Tampa, Florida, USA., Weiss M; ThedaCare Regional Cancer Center, Appleton, Wisconsin, USA., Anderson DM; Metro-Minnesota Community Oncology Research Consortium, St Louis Park, Minnesota, USA., Stadler WM; University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA., Hoff OC; Metro-Minnesota Community Oncology Research Consortium, St Louis Park, Minnesota, USA., Rivera DR; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA., Kluetz PG; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA., Mandrekar SJ; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota, USA., Piantadosi S; Brigham and Women's Hospital, Boston, Massachusetts, USA.
Publikováno v:
Cancer [Cancer] 2024 Aug 28. Date of Electronic Publication: 2024 Aug 28.
Autor:
Casak SJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kumar V; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Song C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Yuan M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Amatya AK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Cheng J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Mishra-Kalyani PS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Lemery SJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Auth D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Davis G; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Fashoyin-Aje LA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 15; Vol. 30 (16), pp. 3371-3377.
Autor:
Barbato MI; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bradford D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ren Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Aungst SL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Miller CP; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pan L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Zirkelbach JF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Li Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bi Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Fan J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Grimstein M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Dorff SE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Amatya AK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Mishra-Kalyani PS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Scepura B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Schotland P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Udoka O; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ojofeitimi I; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Leighton JK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Rahman NA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Singh H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Drezner N; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 15; Vol. 30 (16), pp. 3364-3370.